ScreenPoint Medical
Latest round
- Series C
Last raised
- Jul 2021
Total raised
- $28M
Investors
- 3
About ScreenPoint Medical
ScreenPoint Medical BV delivers innovative artificial intelligence solutions aimed at improving breast cancer detection accuracy. Their flagship product, Transpara, enhances mammography readings through advanced deep learning technology. ScreenPoint Medical BV, founded in 2014 in the Netherlands, specializes in artificial intelligence for breast cancer detection. The company has not undergone any major pivots and does not have any known subsidiaries. Its CEO, Mark Koeniguer, leads the company as it focuses on integrating AI solutions into clinical workflows. ScreenPoint Medical specializes in advanced artificial intelligence solutions for breast cancer detection, with its core product being Transpara. Transpara is a deep learning algorithm designed to enhance the accuracy of mammography readings, specifically for 2D and 3D imaging. The technology assists radiologists by providing risk assessments and improving detection capabilities, especially in patients with dense breast tissue. Released in 2014, Transpara has been integrated into clinical workflows across various healthcare environments, including hospitals and imaging centers in North America and Europe. The company's clientele includes radiologists and healthcare institutions, with a focus on improving patient outcomes through early cancer detection and streamlined screening processes. ScreenPoint Medical generates revenue primarily through B2B transactions with healthcare providers, offering its Transpara software as a subscription service that integrates into existing imaging workflows. The company's business model emphasizes direct partnerships with hospitals and diagnostic imaging centers, allowing for customized installations and ongoing support. Pricing structures are tailored to client needs and may vary based on the scope of implementation, including training and technical assistance. Transpara, as a flagship product, serves as the central offering in these transactions, enabling healthcare facilities to enhance their mammography services and ultimately improve diagnostic efficiency and patient care.
Who invested in ScreenPoint Medical
3 investors across 1 round
See all investors in ScreenPoint Medical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jul 27, 2021
Amount
$28M
Investors
Questions about ScreenPoint Medical
Who invested in ScreenPoint Medical?
ScreenPoint Medical has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ScreenPoint Medical raised?
ScreenPoint Medical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ScreenPoint Medical last raise money?
ScreenPoint Medical's most recent round on record is a Series C, in Jul 2021.
What does ScreenPoint Medical do?
ScreenPoint Medical BV delivers innovative artificial intelligence solutions aimed at improving breast cancer detection accuracy.
Where is ScreenPoint Medical headquartered?
ScreenPoint Medical is headquartered in Netherlands.
Which VCs invest in companies like ScreenPoint Medical?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at ScreenPoint Medical's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like ScreenPoint Medical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.